The group said it would take a 329-million euro ($362 million) writedown on the robot-assisted endovascular cardiology business, which it acquired as part of the 1 billion-euro Corindus acquisition in 2019.
The U.S. government on May 11 will end the COVID-19 Public Health Emergency (PHE) that allowed millions of Americans to receive vaccines, tests, and treatments at no cost during the pandemic.
The White House said it would use existing funding to pay for the tests since it has been unsuccessful so far in getting Congress to pass a bill to put more money towards the U.S. COVID-19 response.
The United States on Tuesday urged delaying a deadline for a World Trade Organization decision relating to the production of COVID-19 treatments and tests, the U.S. trade representative’s office said.
Federal investigators on Wednesday recommended that the U.S. Food and Drug Administration revise its emergency use authorization (EUA) policies for tests to ensure better availability and quality during future infectious disease outbreaks.
The United States will boost its stockpile of at-home COVID-19 tests, ordering more than 100 million tests from domestic manufacturers, the White House said on Thursday, but warned it was a short-term solution.
Starting next week, Americans will not be able to order free at-home COVID tests from a website set up by the U.S. government due to limited supply.
Abbott Laboratories said on Wednesday it was set to recapture some of the market share in the baby formula business as the company restarts manufacturing at its troubled Michigan facility in the United States.
Less than a month after a hard-won deal was reached on a partial waiver of intellectual property rights for COVID-19 vaccines, a fresh battle may be looming at the World Trade Organization over extending the waiver to treatments and tests.